Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive acute myeloid leukemia. CHMFL-FLT3-122 significantly suppressed the tumor growth in MV4-11 cell inoculated xenograft model (50 mg/kg) without exhibiting obvious toxicity in vivo.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 22,500 | |||
5 mg | 在庫あり | ¥ 55,000 | |||
10 mg | 在庫あり | ¥ 82,000 | |||
25 mg | 在庫あり | ¥ 135,000 | |||
50 mg | 在庫あり | ¥ 197,000 | |||
100 mg | 在庫あり | ¥ 271,000 | |||
500 mg | 在庫あり | ¥ 542,000 |
説明 | CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive acute myeloid leukemia. CHMFL-FLT3-122 significantly suppressed the tumor growth in MV4-11 cell inoculated xenograft model (50 mg/kg) without exhibiting obvious toxicity in vivo. |
別名 | CHMFLFLT3122, CHMFL FLT3 122 |
分子量 | 471.55 |
分子式 | C26H29N7O2 |
CAS No. | 1839150-56-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1eq. HCl: 90.0 mg/mL (190.9 mM)
DMSO: 90.0 mg/mL (190.9 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CHMFL-FLT3-122 1839150-56-9 Angiogenesis Tyrosine Kinase/Adaptors FLT CHMFLFLT-3122 CHMFLFLT3122 CHMFL FLT3 122 CHMFLFLT 3122 Inhibitor inhibitor inhibit